Global Ulcerative Colitis Immunology Drugs Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Ulcerative Colitis Immunology Drugs

• 1.1 Definition of Ulcerative Colitis Immunology Drugs
• 1.2 Ulcerative Colitis Immunology Drugs Segment by Type
  • 1.2.1 Global Ulcerative Colitis Immunology Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Adalimumab
  • 1.2.3 Certolizumab Pegol
  • 1.2.4 Tofacitinib
  • 1.2.5 Etanercept
  • 1.2.6 Golimumab
  • 1.2.7 Abatacept
  • 1.2.8 Infliximab
  • 1.2.9 Others
• 1.3 Ulcerative Colitis Immunology Drugs Segment by Applications
  • 1.3.1 Global Ulcerative Colitis Immunology Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Rheumatoid Arthritis
  • 1.3.3 Crohn's Disease(CD)
  • 1.3.4 Ankylosing Spondylitis(AS)
  • 1.3.5 Psoriasis(Ps)
  • 1.3.6 Ulcerative Colitis(UC)
• 1.4 Global Ulcerative Colitis Immunology Drugs Overall Market
  • 1.4.1 Global Ulcerative Colitis Immunology Drugs Revenue (2014-2025)
  • 1.4.2 Global Ulcerative Colitis Immunology Drugs Production (2014-2025)
  • 1.4.3 North America Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Ulcerative Colitis Immunology Drugs
• 2.3 Manufacturing Process Analysis of Ulcerative Colitis Immunology Drugs
• 2.4 Industry Chain Structure of Ulcerative Colitis Immunology Drugs

3 Development and Manufacturing Plants Analysis of Ulcerative Colitis Immunology Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Ulcerative Colitis Immunology Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Ulcerative Colitis Immunology Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Ulcerative Colitis Immunology Drugs Production and Capacity Analysis
• 4.2 Ulcerative Colitis Immunology Drugs Revenue Analysis
• 4.3 Ulcerative Colitis Immunology Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Ulcerative Colitis Immunology Drugs Regional Market Analysis

• 5.1 Ulcerative Colitis Immunology Drugs Production by Regions
  • 5.1.1 Global Ulcerative Colitis Immunology Drugs Production by Regions
  • 5.1.2 Global Ulcerative Colitis Immunology Drugs Revenue by Regions
• 5.2 Ulcerative Colitis Immunology Drugs Consumption by Regions
• 5.3 North America Ulcerative Colitis Immunology Drugs Market Analysis
  • 5.3.1 North America Ulcerative Colitis Immunology Drugs Production
  • 5.3.2 North America Ulcerative Colitis Immunology Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Ulcerative Colitis Immunology Drugs Import and Export
• 5.4 Europe Ulcerative Colitis Immunology Drugs Market Analysis
  • 5.4.1 Europe Ulcerative Colitis Immunology Drugs Production
  • 5.4.2 Europe Ulcerative Colitis Immunology Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Ulcerative Colitis Immunology Drugs Import and Export
• 5.5 China Ulcerative Colitis Immunology Drugs Market Analysis
  • 5.5.1 China Ulcerative Colitis Immunology Drugs Production
  • 5.5.2 China Ulcerative Colitis Immunology Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Ulcerative Colitis Immunology Drugs Import and Export
• 5.6 Japan Ulcerative Colitis Immunology Drugs Market Analysis
  • 5.6.1 Japan Ulcerative Colitis Immunology Drugs Production
  • 5.6.2 Japan Ulcerative Colitis Immunology Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Ulcerative Colitis Immunology Drugs Import and Export
• 5.7 Southeast Asia Ulcerative Colitis Immunology Drugs Market Analysis
  • 5.7.1 Southeast Asia Ulcerative Colitis Immunology Drugs Production
  • 5.7.2 Southeast Asia Ulcerative Colitis Immunology Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Ulcerative Colitis Immunology Drugs Import and Export
• 5.8 India Ulcerative Colitis Immunology Drugs Market Analysis
  • 5.8.1 India Ulcerative Colitis Immunology Drugs Production
  • 5.8.2 India Ulcerative Colitis Immunology Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Ulcerative Colitis Immunology Drugs Import and Export

6 Ulcerative Colitis Immunology Drugs Segment Market Analysis (by Type)

• 6.1 Global Ulcerative Colitis Immunology Drugs Production by Type
• 6.2 Global Ulcerative Colitis Immunology Drugs Revenue by Type
• 6.3 Ulcerative Colitis Immunology Drugs Price by Type

7 Ulcerative Colitis Immunology Drugs Segment Market Analysis (by Application)

• 7.1 Global Ulcerative Colitis Immunology Drugs Consumption by Application
• 7.2 Global Ulcerative Colitis Immunology Drugs Consumption Market Share by Application (2014-2019)

8 Ulcerative Colitis Immunology Drugs Major Manufacturers Analysis

• 8.1 Janssen Biotech, Inc.
  • 8.1.1 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
  • 8.1.2 Janssen Biotech, Inc. Product Introduction, Application and Specification
  • 8.1.3 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Bristol-Myers Squibb Company
  • 8.2.1 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Production Sites and Area Served
  • 8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
  • 8.2.3 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 AbbVie Inc.
  • 8.3.1 AbbVie Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
  • 8.3.2 AbbVie Inc. Product Introduction, Application and Specification
  • 8.3.3 AbbVie Inc. Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 UCBCares
  • 8.4.1 UCBCares Ulcerative Colitis Immunology Drugs Production Sites and Area Served
  • 8.4.2 UCBCares Product Introduction, Application and Specification
  • 8.4.3 UCBCares Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 AMGEN
  • 8.5.1 AMGEN Ulcerative Colitis Immunology Drugs Production Sites and Area Served
  • 8.5.2 AMGEN Product Introduction, Application and Specification
  • 8.5.3 AMGEN Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Celltrion Healthcare
  • 8.6.1 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Production Sites and Area Served
  • 8.6.2 Celltrion Healthcare Product Introduction, Application and Specification
  • 8.6.3 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Biogen
  • 8.7.1 Biogen Ulcerative Colitis Immunology Drugs Production Sites and Area Served
  • 8.7.2 Biogen Product Introduction, Application and Specification
  • 8.7.3 Biogen Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Genentech USA, Inc.
  • 8.8.1 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
  • 8.8.2 Genentech USA, Inc. Product Introduction, Application and Specification
  • 8.8.3 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 ROCHE
  • 8.9.1 ROCHE Ulcerative Colitis Immunology Drugs Production Sites and Area Served
  • 8.9.2 ROCHE Product Introduction, Application and Specification
  • 8.9.3 ROCHE Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Pfizer Inc.
  • 8.10.1 Pfizer Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
  • 8.10.2 Pfizer Inc. Product Introduction, Application and Specification
  • 8.10.3 Pfizer Inc. Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Ulcerative Colitis Immunology Drugs Market

• 9.1 Global Ulcerative Colitis Immunology Drugs Market Trend Analysis
  • 9.1.1 Global Ulcerative Colitis Immunology Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Ulcerative Colitis Immunology Drugs Regional Market Trend
  • 9.2.1 North America Ulcerative Colitis Immunology Drugs Forecast 2019-2025
  • 9.2.2 Europe Ulcerative Colitis Immunology Drugs Forecast 2019-2025
  • 9.2.3 China Ulcerative Colitis Immunology Drugs Forecast 2019-2025
  • 9.2.4 Japan Ulcerative Colitis Immunology Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Ulcerative Colitis Immunology Drugs Forecast 2019-2025
  • 9.2.6 India Ulcerative Colitis Immunology Drugs Forecast 2019-2025
• 9.3 Ulcerative Colitis Immunology Drugs Market Trend (Product Type)
• 9.4 Ulcerative Colitis Immunology Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Ulcerative Colitis Immunology Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List